Liquidia Corporation (LQDA)
NASDAQ: LQDA · IEX Real-Time Price · USD
11.08
+0.09 (0.82%)
At close: Jul 19, 2024, 4:00 PM
11.11
+0.03 (0.23%)
Pre-market: Jul 22, 2024, 8:40 AM EDT
Liquidia Employees
Liquidia had 145 employees as of December 31, 2023. The number of employees increased by 82 or 130.16% compared to the previous year.
Employees
145
Change (1Y)
82
Growth (1Y)
130.16%
Revenue / Employee
$110,117
Profits / Employee
-$742,655
Market Cap
846.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Healthcare Services Group | 33,400 |
InnovAge Holding | 2,100 |
GeneDx Holdings | 1,000 |
Pacira BioSciences | 712 |
AbCellera Biologics | 586 |
Harrow Health | 315 |
Humacyte | 185 |
Cogent Biosciences | 164 |
LQDA News
- 4 weeks ago - Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH) - GlobeNewsWire
- 2 months ago - Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD - GlobeNewsWire
- 3 months ago - Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 months ago - Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder - GlobeNewsWire
- 4 months ago - Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024 - GlobeNewsWire
- 5 months ago - United Therapeutics starts litigation with FDA for allowing Liquidia's drug application - Reuters